Cargando…

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine

An observational post-licensure (Phase IV) retrospective large-database safety study was conducted at Kaiser Permanente, a US integrated medical care organization, to assess the safety of Tetanus Toxoid, Reduced Diphtheria Toxoid and 5-Component Acellular Pertussis Vaccine (Tdap5) administered as pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxter, Roger, Hansen, John, Timbol, Julius, Pool, Vitali, Greenberg, David P., Johnson, David R., Decker, Michael D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137522/ https://www.ncbi.nlm.nih.gov/pubmed/27388557 http://dx.doi.org/10.1080/21645515.2016.1201622

Ejemplares similares

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
por: Park, Hee-Jin, et al.
Publicado: (2019)

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
por: Oliver, Sara E., et al.
Publicado: (2020)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

1089 Safety and Immunogenicity of DTaP-IPV (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliovirus Vaccine) Compared to DAPTACEL(®) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) + IPOL(®) (Poliovirus Vaccine Inactivated) as the 5th Dose in Children 4 to 6 Years of Age
por: Smith, Michael, et al.
Publicado: (2014)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
por: Cho, Hye-Kyung, et al.
Publicado: (2021)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice
por: Komla, Essie, et al.
Publicado: (2021)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine
por: Rose, Markus A, et al.
Publicado: (2013)

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation
por: Castillo, Sonsire Fernández, et al.
Publicado: (2016)

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
por: Prygiel, Marta, et al.
Publicado: (2023)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Mass Spectrometric Analysis of Multiple Pertussis Toxins and Toxoids
por: Williamson, Yulanda M., et al.
Publicado: (2010)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
por: Myers, Tanya, et al.
Publicado: (2018)

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
por: Capeding, Maria Z Rosario, et al.
Publicado: (2003)

Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards
por: Choi, Chan Woong, et al.
Publicado: (2018)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
por: Yu, Rui, et al.
Publicado: (2016)

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
por: Switzer, Charlotte, et al.
Publicado: (2021)

Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
por: Jackson, Lisa A, et al.
Publicado: (2009)

Tetanus Toxoid‐Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth
por: Herold, Joerg, et al.
Publicado: (2014)

Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India
por: Singh, Abhishek, et al.
Publicado: (2012)

A rare case of cellulitis after tetanus toxoid (TT) vaccination
por: AlBassri, Tala K., et al.
Publicado: (2020)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

Living standard and access to tetanus toxoid immunization among women in Bangladesh
por: Islam, Ummay Nayeema, et al.
Publicado: (2022)

Investigating preparation and characterisation of diphtheria toxoid‐loaded on sodium alginate nanoparticles
por: Aghamiri, Samira, et al.
Publicado: (2022)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

Cannot write session to /tmp/vufind_sessions/sess_bkg0n3nct3jjn7mfgumi1rgdch